Takeda U.S. president preps for departure; Lexicon prices a follow-on offering;

@FierceBiotech: Lundbeck CEO booted for ethics breach after a biotech's 'gift' comes to light. Article | Follow @FierceBiotech

@JohnCFierce: CAR-T player Juno picks up 'breakthrough' status for lead cancer therapy. Story | Follow @JohnCFierce

@DamianFierce:  $BMRN + $RNA sub-question: Does drisapersen qualify for a future rare pediatric disease voucher? | Follow @DamianFierce

> Crain's Chicago is reporting that Takeda's president for North America, Doug Cole, is preparing to leave the company after 22 years. Cole has been president of Takeda Pharmaceuticals U.S. for the past three years. A company spokesperson says he's going to start exploring his options. Story

> Lexicon Pharmaceuticals ($LXRX) has priced a $50 million offering. Release

Medical Device News

@FierceMedDev: ICYMI Friday: Tandem partners for open-source software to improve insulin pump data access. Story | Follow @FierceMedDev

@EmilyWFierce: #FDA increases safety guidance for power morcellator devices. More | Follow @EmilyWFierce

> Reva raises $25M to get CE mark for bioresorbable scaffold. Story

> FDA approves Avantis Third Eye device for colonoscopies. Article

Pharma News

@FiercePharma: UPDATED: NewLink, Merck sign Ebola vaccine licensing pact. More | Follow @FiercePharma

@CarlyHFierce: Marijn Dekkers' tennis partner takes Xarelto. More | Follow @CarlyHFierce

> Lundbeck CEO exits in disgrace, endangering key new launches. Report

> U.K. gatekeepers toughest on cancer meds--and getting tougher all the time. Story

> Drug prices plus low reimbursements force cancer docs to sell out. Article

CRO News

> Parexel recruits NextDocs to its stable of eClinical collaborators. More

> PRA and INC trade up amid a warm reception for CRO debuts. Report

> Medidata and TransCelerate beat the drum for risk-based monitoring. Story

> Feds want more trial results made public. Item

> AMRI gets its desert branch back online after a profit-sapping outage. Article

Biotech IT News

> NCI sees role for feds in validating, processing wearables data. Article

> Novartis VC unit co-leads $53M investment in BioNano Genomics. Story

> Cambrian raises $10M for DNA printing tech used by GSK. News

> NIH cites European precedent in call for disclosure of clinical trial data. Report

> GSK, Medidata report on positive pilot of mHealth in clinical trials. Article

Animal Health News

> Petco boosts animal health presence with purchase of Drs. Foster & Smith. Item

> Are farmed fish contributing to the rise of antibiotic resistance? Article

> Piedmont sets lofty goals for pipeline of 25 veterinary drugs. More

> U.K. launches $3M imaging program to improve pig herd health and production. Story

> Embattled Zoetis courts investors as activist shareholder Ackman looms. Article

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.